Home>Topics>Stocks>Roche Holding AG

Roche Holding AG

  1. All
  2. Stock Reports
  3. Fund Reports
  4. Headlines
  1. Chugai soars on report of talks to become Roche's 100 pct unit

    Headlines

    Sun, 17 Aug 2014

    TOKYO, Aug 18 (Reuters) - Chugai Pharmaceutical Co Ltd shares rose 21 percent to a record high following a media report that Roche Holding AG is in talks to buy the almost 40 percent stake in the Japanese firm that it doesn't already own for about $10 billion.

  2. Chugai denies talks with Roche regarding a takeover

    Headlines

    Sat, 16 Aug 2014

    TOKYO, Aug 17 (Reuters) - Chugai Pharmaceutical Co Ltd has denied a media report saying Roche Holding AG is in talks to buy the almost 40 percent stake in the Japanese company that it does not...

  3. Roche to offer $10 billion for rest of Chugai: Bloomberg

    Headlines

    Fri, 15 Aug 2014

    (Reuters) - Roche Holding AG is in talks to buy the almost 40 percent stake in Japan's Chugai Pharmaceutical Co Ltd that it does not already own for about $10 billion, Bloomberg reported, citing people familiar with the matter.

  4. UPDATE 1-Roche to offer $10 bln for rest of Chugai - Bloomberg

    Headlines

    Fri, 15 Aug 2014

    Aug 15 (Reuters) - Roche Holding AG is in talks to buy the almost 40 percent stake in Japan's Chugai Pharmaceutical Co Ltd that it does not already own for about $10 billion, Bloomberg reported,...

  5. Roche to offer $10 bln for rest of Chugai - Bloomberg

    Headlines

    Fri, 15 Aug 2014

    Aug 15 (Reuters) - Roche Holding AG is in talks to buy the almost 40 percent stake in Japan's Chugai Pharmaceutical Co Ltd that it does not already own for about $10 billion, Bloomberg reported, citing people familiar with the matter. (http://bloom.bg/1yF2JNH)

  6. Gilead says wins favorable ruling on hep C drug

    Headlines

    Fri, 15 Aug 2014

    Aug 15 (Reuters) - Gilead Sciences Inc said an arbitration panel has ruled in its favor, rejecting patent infringement claims from Roche Holding AG , related to Gilead's hepatitis C drug, Sovaldi.

  7. Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies

    Headlines

    Tue, 12 Aug 2014

    Central roles in I-O are occupied by Merck & Co. (NYSE: MRK ), Bristol-Myers, AstraZeneca PLC (NYSE: AZN ) and Roche Holding AG ( OTCQX:RHHBY ) in various stages of clinical trials, but with a common scientific theme - the inhibition of programmed

  8. New Morningstar Analyst Report for Roche Holding AG

    Stock Reports

    Mon, 28 Jul 2014

    The complexity of Roche's biologic treatments for cancer supports its wide moat.

  9. Roche Holding AG's (RHHBY) CEO Daniel O'Day on H1 2014 Results - Earnings Call Transcript

    Headlines

    Thu, 24 Jul 2014

    Roche Holding AG ( OTCQX:RHHBY ) H1 2014 Earnings Call July 24, 2014 7:00 am ET Executives Severin Schwan - Chief Executive Officer and Director

  10. BRIEF-Roche CEO-"too early" to make a decision on crenezumab

    Headlines

    Thu, 24 Jul 2014

    July 24 (Reuters) - Roche Holding AG : * CEO says "too early" to make a decision on whether to take alzheimer's drug

« Prev12Next »
Content Partners